Observational studyMedicine2019

High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin.

Yunzhong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.